Prawo i regulacje · 14/08/2023

U.S. Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, Valued at $68 Billion

The U.S. Federal Trade Commission has approved Pfizer's acquisition of BioNTech, a German biotechnology company, valued at $68 billion, following a thorough review process